Delta(9)-tetrahydrocannabinol enhances an increase of plasma corticosterone levels induced by forced swim-stress

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 12, 2009, Pages 2065-2067

  Sano, Kazunori ^a   Koushi, Emi ^a   Irie, Keiichi ^a   Higuchi, Sei ^a   Tsuchihashi, Ryota ^a   Kinjo, Junei ^a   Egashira, Nobuaki ^b   Oishi, Ryozo ^b   Uchida, Naoki ^c   Nagai, Hiroshi ^c   Nishimura, Ryoji ^c   Tanaka, Hiroyuki ^a   Morimoto, Satoshi ^a   Mishima, Kenichi ^a   Iwasaki, Katsunori ^a   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Corticosterone; Delta(9) tetrahydrocannabinol; Forced swim stress

Indexed keywords

CANNABINOID 1 RECEPTOR ANTAGONIST; CORTICOSTERONE; DRONABINOL; STRESS HORMONE;

ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE PREDISPOSITION; FORCED SWIMMING TEST; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; RISK FACTOR;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MICE; MOBILITY LIMITATION; PITUITARY-ADRENAL SYSTEM; PSYCHOTROPIC DRUGS; RECEPTOR, CANNABINOID, CB1; STRESS, PHYSIOLOGICAL; SWIMMING; TETRAHYDROCANNABINOL;

EID: 73449129020     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.2065     Document Type: Article

References (25)

1. Johnson E. O., Kamilaris T. C., Chrousos G. P., Gold P. W., Neurosci. Biobehav. Rev., 16, 115-130 (1992).
2. Linkowski P., Mendlewicz J., Leclercq R., Brasseur M., Hubain P., Golstein J., Copinschi G., Van Cauter E., J. Clin. Endocrinol. Metab., 61, 429-438 (1985).
3. Lowy M. T., Reder A. T., Antel J. P., Meltzer H. Y., Am. J. Psychiatry, 141, 1365-1370 (1984).
4. Substance Abuse and Mental Health Services Administration, "Substance Abuse and Mental Health Services Administration, Results from the 2003 National Survey on Drug Use and Health: National Findings," Substance Abuse and Mental Health Services Administration, Rockville, 2004.
5. Bovasso G. B., Am. J. Psychiatry, 158, 2033-2037 (2001).
6. Hungund B. L., Vinod K. Y., Kassir S. A., Basavarajappa B. S., Yalamanchili R., Cooper T. B., Mann J. J., Arango V., Mol. Psychiatry, 9, 184-190 (2004).
7. Pagotto U., Marsicano G., Cota D., Lutz B., Pasquali R., Endocr. Rev., 27, 73-100 (2006).
8. Bisognoa T., Berrenderob F., Ambrosino G., Cebeira M., Ramos J. A., Fernandez-Ruiz J. J., Di Marzo V., Biochem. Biophys. Res. Commun., 256, 377-380 (1999).
9. Herkenham M., Lynn A. B., Johnson M. R., Melvin L. S., de Costa B. R., Rice K. C., J. Neurosci., 11, 563-583 (1991).
10. Di S., Malcher-Lopes R., Halmos K. C., Tasker J. G., J. Neurosci., 23, 4850-4857 (2003).
11. Manzanares J., Corchero J., Fuentes J. A., Brain Res., 839, 173-179 (1999).
12. Porsolt R. D., Bertin A., Jalfre M., Arch. Int. Pharmacodyn. Ther., 229, 327-336 (1977).
13. Egashira N., Matsuda T., Koushi E., Higashihara F., Mishima K., Chidori S., Hasebe N., Iwasaki K., Nishimura R., Oishi R., Fujiwara M., Eur. J. Pharmacol., 589, 117-121 (2008).
14. Egashira N., Matsuda T., Koushi E., Mishima K., Iwasaki K., Shoyama Y., Fujiwara M., Eur. J. Pharmacol., 550, 117-122 (2006).
15. Murray F., Smith D. W., Hutson P. H., Eur. J. Pharmacol., 583, 115-127 (2008).
16. Hill M. N., Patel S., Carrier E. J., Rademacher D. J., Ormerod B. K., Hillard C. J., Gorzalka B. B., Neuropsychopharmacology, 30, 508-515 (2005).
17. Hill M. N., Carrier E. J., Ho W. S., Shi L., Patel S., Gorzalka B. B., Hillard C. J., Hippocampus, 18, 221-226 (2008).
18. Mailleux P., Vanderhaeghen J. J., Neurosci. Lett., 156, 51-53 (1993).
19. Gordon J. H., Bromley B. L., Gorski R. A., Zimmermann E., Pharmacol. Biochem. Behav., 8, 603-608 (1978).
20. Jackson A. L., Murphy L. L., Neuroendocrinology, 65, 446-452 (1997).
21. Pryce G., Giovannoni G., Baker D., Neurosci. Lett., 341, 164-166 (2003).
22. Schramm-Sapyta N. L., Cha Y. M., Chaudhry S., Wilson W. A., Swartzwelder H. S., Kuhn C. M., Psychopharmacology, 191, 867-877 (2007).
23. Haller J., Mátyás F., Soproni K., Varga B., Barsy B., Németh B., Mikics E., Freund T. F., Hájos N., Eur. J. Neurosci., 25, 2445-2456 (2007).
24. Pagotto U., Marsicano G., Fezza F., Theodoropoulou M., Grübler Y., Stalla J., Arzberger T., Milone A., Losa M., Di Marzo V., Lutz B., Stalla G. K., J. Clin. Endocrinol. Metab., 86, 2687-2696 (2001).
25. Hsu D. T., Lombardo K. A., Herringa R. J., Bakshi V. P., Roseboom P. H., Kalin N. H., Neuroscience, 105, 911-921 (2001).